AACR Annual Meeting

AACR Annual Meeting
Name	AACR Annual Meeting
Status	Active
Genre	Scientific conference
Date	Annual
Frequency	Annual
Location	Rotating venues (United States, Canada, Europe)
Country	United States
First	1907 (American Association for Cancer Research founding year)
Organizer	American Association for Cancer Research

AACR Annual Meeting The AACR Annual Meeting is the flagship scientific conference of the American Association for Cancer Research, gathering researchers, clinicians, industry leaders, patient advocates, and policy makers to present advances in cancer biology, translational science, clinical trials, and precision medicine. The meeting synthesizes content across basic science, drug development, epidemiology, and public health, serving as a nexus for collaborations among academic institutions, biotechnology firms, pharmaceutical companies, and regulatory agencies.

History

The meeting traces roots to the founding of the American Association for Cancer Research alongside institutions such as Johns Hopkins University, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, National Cancer Institute, and Roswell Park Comprehensive Cancer Center. Over decades, presentations have included work from investigators associated with Harvard University, Stanford University School of Medicine, University of California, San Francisco, Massachusetts General Hospital, MD Anderson Cancer Center, Yale University, Columbia University, University of Pennsylvania, University of Chicago, University of Texas Southwestern Medical Center, and University of Michigan. Landmark discoveries showcased at meetings have involved researchers from Cold Spring Harbor Laboratory, Salk Institute for Biological Studies, Broad Institute, Scripps Research, Fred Hutchinson Cancer Research Center, University of Cambridge, University of Oxford, Karolinska Institutet, Institut Curie, Max Planck Society, Weizmann Institute of Science, Imperial College London, University of Toronto, and McGill University. Historically, keynote lecturers have included scientists affiliated with National Institutes of Health, Food and Drug Administration, European Medicines Agency, Bill & Melinda Gates Foundation, Wellcome Trust, and Nobel laureates associated with Rockefeller University, University of California, Berkeley, ETH Zurich, Columbia University Irving Medical Center, and Cambridge University. Venue rotations have linked the meeting to cities hosting institutions such as Boston, San Diego, Chicago, Philadelphia, New Orleans, Tampa, Atlanta, Washington, D.C., Toronto, and San Francisco.

Organization and Governance

The meeting is organized by the American Association for Cancer Research leadership, including boards with members from University of Pittsburgh Medical Center, Vanderbilt University Medical Center, Cleveland Clinic, Northwestern University Feinberg School, University of North Carolina at Chapel Hill, Johns Hopkins School of Medicine, University of California, Los Angeles, and Duke University School of Medicine. Steering committees coordinate with program directors from American Society of Clinical Oncology-affiliated groups, collaborators at European Society for Medical Oncology, and liaisons to agencies like National Cancer Institute and Centers for Disease Control and Prevention. Governance structures incorporate input from representatives of Pfizer, Novartis, Roche, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Amgen, Gilead Sciences, Eli Lilly and Company, Johnson & Johnson, and biotechnology startups incubated at Cambridge Innovation Center and Biolabs. Ethics and conflict-of-interest policies reference standards similar to those at Association of American Medical Colleges and World Health Organization committees.

Program and Scientific Content

Scientific content spans sessions on molecular oncology with contributions from labs at Cold Spring Harbor Laboratory, Broad Institute, Salk Institute for Biological Studies, and Max Planck Institute for Biochemistry; translational research drawing investigators from Dana-Farber Cancer Institute, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center; and clinical trial results involving collaborators such as National Cancer Institute, European Organisation for Research and Treatment of Cancer, and cooperative groups like SWOG and Alliance for Clinical Trials in Oncology. Topics include immuno-oncology with work from teams at Parker Institute for Cancer Immunotherapy, targeted therapies pioneered at Institute of Cancer Research, genomics from Wellcome Sanger Institute and European Molecular Biology Laboratory, epigenetics studies from Cold Spring Harbor Laboratory and University of California, San Diego, biomarker development at Fred Hutchinson Cancer Research Center, and liquid biopsy advances linked to University of Pennsylvania and Stanford University. Sessions often feature representatives from regulatory and funding bodies such as Food and Drug Administration, European Medicines Agency, National Institutes of Health, Cancer Research UK, American Cancer Society, and philanthropic funders like Susan G. Komen.

Attendance and Impact

Attendance routinely includes scientists, clinicians, patient advocates, industry delegates, and press from institutions including Harvard Medical School, Yale School of Medicine, UCSF Health, Massachusetts General Hospital Cancer Center, Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, Johns Hopkins Hospital, Mayo Clinic, Cleveland Clinic Cancer Center, and international centers such as Peter MacCallum Cancer Centre and Royal Marsden Hospital. The meeting influences drug approvals by companies like Roche, Merck & Co., Bristol-Myers Squibb, and AstraZeneca and shapes guideline updates by organizations such as National Comprehensive Cancer Network and American Society of Clinical Oncology. Media coverage often involves outlets like The New York Times, The Washington Post, Nature, Science (journal), The Lancet, New England Journal of Medicine, and Cell (journal), amplifying findings to patient communities connected to American Cancer Society and advocacy groups such as LUNGevity Foundation and St. Baldrick's Foundation.

Awards and Recognitions

The meeting features award lectures and prizes with honorees affiliated with Nobel Prize, recipients from institutions like Rockefeller University, Salk Institute, Broad Institute, Cold Spring Harbor Laboratory, Harvard Medical School, Stanford University, and recognition by societies including American Society of Clinical Oncology, European Society for Medical Oncology, Society for Immunotherapy of Cancer, AACR-Armitage Prize, AACR-Millennium Cancer Prize and named lectures honoring pioneers from Roswell Park Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, and Dana-Farber Cancer Institute. Early-career awards spotlight trainees from University of Cambridge, University of Oxford, Karolinska Institutet, Weill Cornell Medicine, Columbia University Irving Medical Center, and University of Toronto.

Satellite Events and Special Sessions

Satellite symposia and workshops draw partners such as PhRMA, BIO (trade association), American Association of Pharmaceutical Scientists, and academic centers including Scripps Research, La Jolla Institute for Immunology, and Beckman Research Institute. Special sessions frequently include tumor boards and educational programs by American Society for Clinical Oncology, survivorship panels with representatives from National Coalition for Cancer Survivorship, and policy forums involving U.S. Congress staff, European Commission health officials, and regulators from Food and Drug Administration and European Medicines Agency.

Controversies and Criticism

Controversies have included debates over industry sponsorship from firms like Pfizer, Roche, Merck & Co., Novartis, and Bristol-Myers Squibb; disclosure practices compared to standards at Association of American Medical Colleges; access and equity concerns raised by advocates from National Organization for Rare Disorders, Friends of Cancer Research, and Global Lung Cancer Coalition; and critiques about trial reporting amplified by journals such as The Lancet Oncology, Journal of Clinical Oncology, Nature Medicine, and New England Journal of Medicine. Discussions have also involved international attendees from China National Cancer Center, All India Institute of Medical Sciences, Samsung Medical Center, and Royal College of Physicians regarding travel restrictions, virtual access, and representation of researchers from Low and Middle-Income Countries.

Category:Medical conferences